Both in Pharmaceuticals
Neuphoria Therapeutics vs Allarity Therapeutics
Over the past year NEUP returned −78.0% and ALLR returned −42.0%; their daily moves had a correlation of 0.11.
NEUP −78.0% ALLR −42.0%Growth of $1, one year, split-adjusted
| Metric | NEUP | ALLR |
|---|---|---|
| Price | $3.39 | $0.8758 |
| Market cap | $18.3M | $13.9M |
| Today | +2.42% | +0.32% |
| 1 month | −8.6% | −25.1% |
| 6 months | −30.4% | −36.5% |
| Year to date | −12.6% | −18.9% |
| 1 year | −78.2% | −39.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 40.4× |
| Net cash | — | -$5.3M |
| Dividend yield | — | — |
| Volatility (60d) | 21.7% | 64.5% |
| Short % of float | 0.4% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).